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Autophagy is a cellular mechanism involved in the bulk degradation of proteins and turnover
of organelle. Several studies have shown the significance of autophagy of the renal tubular
epithelium in rodent models of tubulointerstitial disorder. However, the role of autophagy in
the regulation of human glomerular diseases is largely unknown. The current study aimed to
demonstrate morphological evidence of autophagy and its association with the ultrastruc-
tural changes of podocytes and clinical data in patients with idiopathic nephrotic syndrome,
a disease in which patients exhibit podocyte injury. The study population included 95
patients, including patients with glomerular disease (minimal change nephrotic syndrome
[MCNS], n = 41; idiopathic membranous nephropathy [IMN], n = 37) and 17 control subjects
who underwent percutaneous renal biopsy. The number of autophagic vacuoles and the
grade of foot process effacement (FPE) in podocytes were examined by electron micros-
copy (EM). The relationships among the expression of autophagic vacuoles, the grade of
FPE, and the clinical data were determined. Autophagic vacuoles were mainly detected in
podocytes by EM. The microtubule-associated protein 1 light chain 3 (LC3)-positive area
was co-localized with the Wilms tumor 1 (WT1)-positive area on immunofluorescence
microscopy, which suggested that autophagy occurred in the podocytes of patients with
MCNS. The number of autophagic vacuoles in the podocytes was significantly correlated
with the podocyte FPE score (r = -0.443, p = 0.004), the amount of proteinuria (r = 0.334, p =
0.033), and the level of serum albumin (r = -0.317, p = 0.043) in patients with MCNS. The
FPE score was a significant determinant for autophagy after adjusting for the age in a multi-
ple regression analysis in MCNS patients (p = 0.0456). However, such correlations were not
observed in patients with IMN or in control subjects. In conclusion, the results indicated that
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the autophagy of podocytes is associated with FPE and severe proteinuria in patients with
MCNS. The mechanisms underlying the activation of autophagy in association with FPE in
podocytes should be further investigated in order to elucidate the pathophysiology of MCNS.
Introduction
Minimal change nephrotic syndrome (MCNS) is one of the most common causes of idiopathic
nephrotic syndrome; it is identified in approximately 10–25% of adult patients with the condi-
tion [1]. On histological examination, patients with MCNS show no glomerular lesions on
light microscopy and no specific findings on fluorescence microscopy; however, electron
microscopy (EM) of renal biopsy specimens reveals extensive foot process effacement (FPE) in
the glomerular podocytes [2]. Clinically, massive proteinuria is a main diagnostic and thera-
peutic marker in these patients.
Autophagy is the process through which the bulk degradation of cellular proteins takes
place. The cytoplasmic components are enclosed by double-membrane structures known as
autophagosomes, which are delivered to lysosomes and then form vacuoles in the cell cyto-
plasm [3]. The breakdown products in lysosomes are subsequently recycled back to cytoplasm.
The Atg gene family plays an crucial role in the regulation of cellular autophagy. The p62 gene
encodes several proteins that are important for the initiation and maturation of autophago-
somes [4–7]. The mammalian target of rapamycin (mTOR) is known to be a key governor of
both autophagy and cellular metabolism [8, 9].
The traditional method for observing autophagy within the cell is EM. In the late 1950s, an
electron microscopic study demonstrated autophagy in the lysosomes in mammalian cells
[10]. At the ultrastructural level, an autophagosome is characterized by a double-membraned
structure containing undecomposed cytoplasmic components, which has not fused with a
lysosome. Autophagosomes frequently contain intracellular organelles, such as fragments of
the endoplasmic reticulum and mitochondria [10].
Besides the physiological role of autophagy in cellular homeostasis, the dysregulation of autop-
hagy may be involved in various disease conditions, such as inflammation, aging, metabolic dis-
eases, neurodegenerative disorders and cancer [11–13]. The DNA of mitochondria that escapes
from autophagy leads to Toll-like receptor 9-mediated inflammation and thus induces myocardi-
tis and dilated cardiomyopathy [14]. Recent studies have shown the alteration of autophagy in
tubular epithelial cells in renal tubulointerstitial disorder [8, 15–26]. The podocyte-specific
knockout of the vacuolar protein sorting defective 34 or the prorenin receptor was associated
with severe proteinuria, FPE and the autophagy of numerous podocytes after birth [27–29]. How-
ever, little is known about autophagy in glomerular diseases, in particular, in human idiopathic
nephrotic syndrome in which alteration of the glomerular podocytes plays a critical role [30–32].
We therefore hypothesized that altered autophagy may be involved in the pathophysiology
of MCNS, one of the most common forms of idiopathic nephrotic syndrome. In this study, we
investigated the presence of autophagic vacuoles in glomerular podocytes in renal biopsy spec-
imens by EM and further analyzed its association with the degree of FPE in podocytes and the
amount of proteinuria, both of which are hallmarks of MCNS.
Methods
Subjects
Our study included 95 patients (male, n = 50; female, n = 45) who were admitted to the Unit of
Renal Medicine in Okayama University Hospital and underwent percutaneous renal biopsies
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between February 2007 and January 2015. All procedures in the present study were performed
according to national and institutional ethical guidelines for human studies, and guidelines in
the Declaration of Helsinki. The ethics committee of Okayama University Hospital approved
the study (No. 1607–010). Each patient gave their written informed consent.
Laboratory measurements
Blood was taken from all subjects in the morning after 12 h of fasting. The serum levels of cre-
atinine, total cholesterol, total protein and albumin were obtained using an automated ana-
lyzer (JCA-BM8040; JEOL, Tokyo, Japan). A 24-h urine sample was collected to measure the
urinary levels of total protein. The eGFR was calculated as previously described [33].
Human renal biopsy specimens
Specimens of human renal tissue were obtained by percutaneous renal biopsy. Patients were
diagnosed on the basis of clinical symptoms, laboratory data and immunofluorescence, light
and EM findings [34]. Control renal tissue specimens were obtained from patients who under-
went renal biopsy due to slight asymptomatic proteinuria or hematuria, but in whom glomeru-
lar disease was excluded. Each tissue section obtained was routinely evaluated under a light
and fluorescence microscope (Olympus, Tokyo, Japan).
Electron microscopy
Human kidney specimens were observed by EM as described previously [35]. In brief, tissue
blocks of kidney pieces were immersed in 2.5% glutaraldehyde for 2 hours at 4˚C and subse-
quently fixed with 1% osmium tetroxide. The blocks were then subjected to dehydration, epon
embedding, and ultrathin sectioning. The four serial ultrathin sections were set on a grid and
observed under an electron microscope (H7650; Hitachi, Tokyo, Japan). Two ultrastructural
types of autophagy are recognized: type I and type II autophagy [36–38]. Type I autophagy is
characterized by a condensed ribosome area with a limiting membrane. Type II autophagy is
characterized by the aggregation of ribosomes, forming a condensed ribosome area, which
always includes numerous aggregated lipid droplets in autophagic vacuoles observed in most
of all autophagy. In agreement with previous studies on podocyte autophagy in renal biopsy
specimens [36, 37], type I autophagy accounted for<10% of all autophagy and type II autop-
hagy was mainly observed in this study. Thus, we counted autophagic vacuoles (type II autop-
hagy) and the average number of autophagic vacuoles per glomerulus was determined in each
subject. A quantitative examination was carried out to count the number of podocyte foot pro-
cesses per 10 μm of glomerular basement membrane (GBM) in each glomerulus. The mean
number of podocyte foot processes was determined as the FPE score, as described previously
[39, 40]. Representative electron micrographs used for the evaluation of the podocyte FPE
score are shown in S1 Fig.
Immunofluorescence analysis
Renal biopsy specimens were subjected to immunolabelling of microtubule-associated protein
1 light chain 3 (LC3; a homologue of yeast Atg8, which is localized to membranes of autopha-
gosomes) to investigate its cytosolic and autophagosomal distribution. Immunofluorescence
staining was performed using 4-μm-thick frozen sections of renal biopsy specimens fixed in
cold acetone for 3 min and air dried, as described previously [41]. Double immunofluores-
cence staining were carried out with rabbit polyclonal anti-LC3 (clone PM036; MBL) diluted
1:50 and mouse monoclonal anti-Wilms tumor 1 (WT1) (clone IR055; DAKO), the latter
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reacted with the cytoplasm of glomerular podocytes [42, 43]. The sections were blocked in 3%
bovine serum albumin for 1 hour at room temperature and then left overnight at 4˚C, and
stained with the antibodies described above. Next, secondary antibodies conjugated with fluo-
rescein isothiocyanate (FITC) (sc-2012; anti-rabbit IgG, 1:100 dilution, Santa Cruz) and those
conjugated with rhodamine (sc-2092; anti-mouse IgG, 1:100 dilution, Santa Cruz) were
applied for 1 hour at room temperature. Nuclei were then stained with 4’,6-diamidino-2-phe-
nylindole (DAPI) (Life Technologies). Fluorescence images were obtained using an immuno-
fluorescence microscope (BZ-9000; Keyence, Osaka, Japan).
Statistical analysis
When the data did not follow a normal distribution, they were expressed as the median and
interquartile range. A simple linear regression analysis of the data was performed. A multiple
regression analysis was performed to determine autophagic vacuoles per glomerulus. P values
of< 0.05 were considered to indicate statistical significance. Differences between groups were
analyzed using the Mann-Whitney U-test, or the Steel’s multiple comparison test as appropri-
ate. The statistical analyses were carried out using the JMP software program (version 11; SAS
Institute Inc., Cary, NC, USA).
Results
Patient profiles
The baseline characteristics of the study population are shown in Table 1. The study popula-
tion included 95 patients (median age, 55.0 [28.0–69.0] years). Seventeen of the patients were
control subjects without any significant clinical or pathological abnormalities (17.9%), 41
patients were diagnosed with MCNS (43.2%), and 37 were diagnosed with idiopathic membra-
nous nephropathy (IMN) (38.9%). At the time of renal biopsy, 28 of 41 patients with MCNS
(68.3%) and 9 of 37 patients with IMN (24.3%) had taken corticosteroids and/or immunosup-
pressants, including cyclosporine for the treatment of glomerular disease. Eighteen of 41
patients with MCNS (43.9%) and 13 of 37 patients with IMN (35.1%) exhibited clinical
nephrotic syndrome at the time of renal biopsy.
Morphological evidence of autophagy in renal biopsy specimens
Autophagic vacuoles were mainly detected in the cytoplasm of glomerular podocytes, seldom
detected in that of glomerular mesangial cells or endothelial cells in renal biopsy specimens
observed by EM (Fig 1). The localization of LC3, a marker of autophagy, was investigated by
co-staining with antibodies to WT1, which are expressed in the cytoplasm of glomerular podo-
cytes in nephrotic syndrome [43]. Most of the LC3-positive podocytes in the glomerulus were
co-positive for WT1 (Fig 2), suggesting that autophagy mainly occurred in the glomerular
podocytes.
The number of autophagic vacuoles in podocytes was significantly
associated with proteinuria, serum albumin, and the podocyte foot process
effacement score in patients with MCNS
We next evaluated the relationships among the number of podocyte autophagic vacuoles, FPE
score, and clinical data in patients with MCNS and IMN, who are prone to nephrotic syn-
drome, and in control subjects (Table 2). The number of autophagic vacuoles in podocytes
was positively correlated with the amount of urinary protein and was negatively correlated
with the serum albumin level in patients with MCNS (Fig 3A and 3C), whereas no such
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correlations were recognized in patients with IMN (Fig 3B and 3D). Ultrastructural mor-
phometry revealed that the number of autophagic vacuoles was significantly correlated with
the FPE score in podocytes of MCNS patients (Fig 3E), while no significant correlations were
observed in IMN patients (Fig 3F). In control subjects, no significant correlations were
observed among the number of autophagic vacuoles and proteinuria, serum albumin, or the
FPE score (S2 Fig). Since a decline in autophagic activity may play a role in the aging process
[11–13], we next examined the relationships between age and the autophagic vacuoles in
patients with idiopathic nephrotic syndrome and controls. The number of autophagic vacuoles
in podocytes was significantly correlated with age in control subjects and MCNS patients, but
not in IMN patients (S3 Fig). We further conducted a multiple regression analysis to deter-
mine the autophagic vacuoles per glomerulus. After adjusting for the age as a confounding fac-
tor, the FPE score was found to be a significant determinant for autophagy in podocytes in
patients with MCNS (Table 3). There were no significant determinants for autophagic vacuoles
per glomerulus in patients with IMN (S1 Table) or control subjects (S2 Table) after adjusting
for the age.
Discussion
This is the first study to demonstrate the association between autophagy of glomerular podo-
cytes and proteinuria or hypoalbuminemia, both of which are clinical characteristics in
patients with MCNS and FPE in podocytes, which is an ultrastructural hallmark in MCNS.
At present, little is known about autophagy in podocytes in human glomerular diseases, in
particular in patients with idiopathic nephrotic syndrome. Sato et al. demonstrated ultrastruc-
tural evidence of autophagy in podocytes in human renal biopsy specimens [36, 37]. They
reported that in type I autophagy (approximately 1 μm in diameter), a condensed ribosome










































































eGFR, estimated glomerular filtration rate; MCNS, minimal change nephrotic syndrome; IMN, idiopathic membranous nephropathy.
The clinical data at the time of renal biopsy are expressed as the median value (interquartile range).
a: P<0.05
b: P<0.01 vs. Control
c: P<0.05
d: P<0.01 vs. MCNS.
https://doi.org/10.1371/journal.pone.0228337.t001
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area and a few lipid droplets were observed with a limiting membrane originating from mito-
chondria, while in type II autophagy (3–8 μm in diameter), a condensed ribosome and numer-
ous lipid droplets were observed with a limiting membrane originating from the rough
endoplasmic reticulum. Type II autophagy transformed to autophagosomes and autophagic
vesicles. Their results suggested that type II autophagy may play a more important role in the
clearance of proteins and lipids than type I autophagy. In pediatric patients with IgA nephrop-
athy, which is the most common type of chronic glomerulonephritis [44], the existence of type
I autophagy may be associated with a more progressive histopathological class in comparison
to type II autophagy [38]. In our study, however, the type I autophagy accounted for <10% of
all autophagy, and was much less prevalent than type II autophagy (autophagic vacuoles).
Fig 1. The ultrastructural morphology of autophagy in glomerular podocytes, as observed by electron microscopy. Electron
micrographs of a glomerulus in patients with MCNS (A-C, 73-year-old female; D, 19-year-old female) are shown (A-D). A condensed
ribosome with limiting membranes (type I autophagy) (A and D) and autophagic vacuoles containing lipid droplets and vacuoles (type
II autophagy) (B and C) are indicated by arrows. CL, capillary lumen; Ep, glomerular epithelial cell (podocyte); GBM, glomerular
basement membrane; US, urinary space.
https://doi.org/10.1371/journal.pone.0228337.g001
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Fig 2. Dual immunolabelling of LC3 and WT1 in the glomerulus of an MCNS patient, as detected by immunofluorescence
microscopy (73-year-old, female). Fluorescence micrographs of sections single stained for LC3 with FITC (A), WT1 with rhodamine
(B), and dual stained for LC3 and WT1 (D) are shown. The cell nuclei were stained with DAPI (C). Note the LC3-positive area is co-
localized with the WT1-positive area in panel D.
https://doi.org/10.1371/journal.pone.0228337.g002

























MCNS, minimal change nephrotic syndrome; IMN, idiopathic membranous nephropathy.
Histological data at the time of renal biopsy are expressed as median values (interquartile range).
a: P<0.01 vs. Control
b: P<0.01 vs. MCNS.
https://doi.org/10.1371/journal.pone.0228337.t002
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Fig 3. The relationships between the number of autophagic vacuoles in podocytes and proteinuria, serum albumin, and the foot process
effacement score in patients with MCNS (A, C, E) and IMN (B, D, F). The correlation between the number of the autophagic vacuoles in
podocytes and daily urinary protein (g/day) (A, B), serum albumin (g/dL) (C, D) and the podocyte FPE score (E, F). MCNS, minimal change
nephrotic syndrome; IMN, idiopathic membranous nephropathy.
https://doi.org/10.1371/journal.pone.0228337.g003
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Thus, we evaluated the number of autophagic vacuoles alone. The appearance of autophagy
should be further investigated in other forms of human glomerular diseases, including lupus
nephritis [45] and diabetic nephropathy [26].
The mechanism of interaction between autophagy and FPE in podocytes is largely
unknown. In the podocytes of cathepsin D-knockout mice exhibiting proteinuria, the accumu-
lation of podocin, a slit diaphragm (SD) protein, was co-localized with the lysosome-associated
membrane glycoprotein 1 and the late endosomal marker Rab7 [46]. The granular structures
that accumulated in the podocyte cytoplasm were thus indicated to be autophagosomes and
autolysosomes containing degraded podocin, suggesting a degradation of podocin by autop-
hagy, which eventually leads to the disruption of SD and FPE of podocytes. Another candidate
mediator involved in the interaction between autophagy and FPE is the Ca2+ influx into podo-
cytes. Several studies have shown that Ca2+ in the cytoplasm can regulate the cellular process
of autophagy [47]. Podocyte FPE involves the dynamic reorganization of actin filaments, a
process controlled by the Ca2+ influx, as a modulator of the actin cytoskeleton [48].
Focal segmental glomerulosclerosis (FSGS) is another major cause of idiopathic nephrotic
syndrome. Patients with the disease show podocyte injury, including FPE, podocyte detach-
ment from the GBM, and podocyte loss, eventually leading to end-stage renal disease with a
poorer prognosis than that in MCNS [49]. A recent study showed that the number of autopha-
gosome-positive podocytes in patients with FSGS was significantly lower than that in patients
with MCNS [32]. The study showed, using repeat renal biopsies, that decreased podocyte
autophagy in MCNS patients was associated with the subsequent progression of MCNS to
FSGS. Variants of the apolipoprotein L1 (APOL1) gene in African Americans are known to be
related to FSGS [50]. Both soluble urokinase plasminogen activator receptor (suPAR) and
APOL1 synergistically induced beta 3 integrin activation in podocytes, resulting in the dysre-
gulation of the actin cytoskeleton, thereby leading to podocyte FPE as well as the formation of
dysfunctional autophagosomes [51]. Since we could only obtain a very small number of renal
biopsy specimens from patients with FSGS, it was not possible to compare the degree of podo-
cyte autophagy in our study.
Idiopathic membranous nephropathy (IMN) is one of the most frequent causes of
nephrotic syndrome in adults, especially in the elderly population [52]. A recent report showed
that there is a greater accumulation of LC3-positive vacuoles with the markedly enhanced
expression of p62/SQSTM1 protein, a target of autophagy degradation, in the podocytes of
IMN patients in comparison to controls, suggesting the impaired degradation of this protein
and insufficient autophagy in IMN [31]. Another report demonstrated an increase in Atg3
mRNA in microdissected glomeruli from patients with IMN in comparison to controls [30].
In the current study, we did not recognize a significant increase in the number of autophagic
vacuoles in patients with IMN in comparison to controls. The positive correlation of podocyte
Table 3. A multiple regression analysis to determine autophagic vacuoles per glomerulus in MCNS.
Independent variables β p-value model r2
Urinary protein (g/day) 0.190368 0.1866 0.3071
Serum albumin (g/dL) 0.006299 0.9731
Serum creatinine (μmol/L) -0.192575 0.1709
Total cholesterol (mmol/L) 0.174846 0.3233
Foot process effacement score -0.320560 0.0456�
Adjusted for age. MCNS, minimal change nephrotic syndrome.
�: P<0.05.
https://doi.org/10.1371/journal.pone.0228337.t003
Autophagy and nephrotic syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0228337 January 24, 2020 9 / 15
autophagy with proteinuria, hypoalbuminemia, and FPE, which was observed in patients with
MCNS, was not recognized in patients with IMN in this study. Why we noted no relationship
between podocyte autophagy and proteinuria in the IMN patients in this study is unknown.
We were unable to exclude the possibility that the lower ratio of patients with IMN (24.3%)
than that of those with MCNS (68.3%) taking corticosteroids and/or immunosuppressants
(including cyclosporine) for the treatment of glomerular disease affected the podocyte autop-
hagy. Clinically, patients with MN exhibit the gradual onset of edema and a slow increase in
proteinuria, while those with MCNS exhibit the sudden onset of edema and rapid and massive
proteinuria. While this is highly speculative, the difference in the time course of the disease
appearance and progression might explain why there was no relationship between podocyte
autophagy and proteinuria in IMN patients. Another possible explanation is that IMN is an
immune complex disease while MCNS is not. Certain immune complexes can suppress autop-
hagy in glomerular endothelial cells [53]. Immune complexes including specific antigens, such
as phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A [54] might
affect the interaction of autophagy of podocytes and proteinuria in IMN. Further studies
should be performed to investigate the abnormalities in the system of the autophagic degrada-
tion of podocytes, such as the expression of p62/SQSTM1 protein, which is reported in other
conditions associated with podocyte injury, such as Fabry disease [55, 56].
There are two cellular mechanisms by which misfolded proteins decompose: one is autop-
hagy, which is a lysosome-mediated pathway; the other is the ubiquitin-proteasome system,
which is a non-lysosomal and highly specific pathway through which ubiquitinated proteins
decompose [57]. Previously published data have reported certain interactions between the two
pathways [58]. However, these interactions still remain to be investigated in human podocytes
in healthy individuals and in patients with glomerular diseases, such as nephrotic syndrome.
In injured podocytes, the counterbalancing of cell survival by autophagy and cell death by apo-
ptosis may play an essential role in the progression of glomerular disease [59–62]. Cross-talk
between autophagy and apoptosis via Atg6 homologue beclin 1, which binds to anti-apoptosis
bcl-2 in signal transduction, can regulate both autophagy and apoptosis [63]. This interaction
in the regulation of podocyte death and survival, which could affect proteinuria and glomeru-
losclerosis should be further investigated.
The present study is associated with several limitations and strengths that must be kept in
mind when understanding the results. First, we did not have data from patients with FSGS,
which is a major cause of idiopathic nephrotic syndrome. Since FSGS is less frequent than
MCNS and IMN [44], we did not obtain enough samples from patients with FSGS in our
study. There are still controversial reports describing a significant decrease in number of
autophagic podocytes [32] or an increase in glomerular Atg3 mRNA in relation to autophagy
[30] in patients with FSGS in comparison to patients with MCNS. Second, we did not have
repeat renal biopsy data, which might have enabled us to obtain causative data that would have
allowed us to explore the role of autophagy in disease progression, such as the transition of
MCNS to FSGS [32], or the effects of therapeutic interventions (e.g., rituximab treatment) [64,
65] on autophagy in the podocytes in patients with MCNS. Third, we evaluated the expression
of LC3, a marker of autophagic activities as well as disturbed lysosomal recycling. We did not
evaluate the autophagy flux [66, 67] in this study, as recommended by the guidelines for the
use and interpretation of assays for monitoring autophagy [68]. We were unable to detect the
glomerular expression of p62/SQSTM1 protein, which is degraded by autophagy and therefore
serves as a marker of impaired autophagy (unpublished observation). Fourth, we included
patients who were already undergoing treatment with corticosteroids and/or immunosuppres-
sants at the time of renal biopsy; thus, we could not exclude the possibility that these treat-
ments affected the autophagy status in podocytes. Fifth, this study contained an insufficient
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number of controls who were age-matched with patients with MCNS, so a sufficient number
of age-matched controls should be accumulated in the future.
In conclusion, we have demonstrated that there were significant associations between the
autophagy of glomerular podocytes and proteinuria, hypoalbuminemia, and FPE in podocytes
in patients with MCNS. Such correlations were not recognized in patients with IMN, another
form of proteinuric glomerular disease. Further investigations should be performed to clarify
the autophagic flux and autophagic activities in podocytes in MCNS. The precise mechanism
of molecular interaction between autophagy and FPE in the podocytes should be examined,
since modulation of this interaction may have novel therapeutic applications in the treatment
of MCNS.
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S1 Table. A multiple regression analysis to determine autophagic vacuoles per glomerulus
in IMN.
(DOCX)
S2 Table. A multiple regression analysis to determine autophagic vacuoles per glomerulus
in control.
(DOCX)
S1 Fig. Representative electron micrographs used for the evaluation of foot process efface-
ment in glomerular podocytes. Panel A shows an FPE score of�15 (15-years-old, male, con-
trol). Panel B shows an FPE score of�8 to<15 (19-year-old, female, MCNS). Panel C shows
an FPE score of<8 (26-year-old, male, MCNS).
(TIF)
S2 Fig. The relationship between the number of autophagic vacuoles and urinary protein
(g/day) (A), serum albumin (mg/dL) (B), and the foot process effacement score (C) in con-
trol subjects (n = 17). There were no significant correlations between the number of autopha-
gic vacuoles and any of the parameters.
(TIF)
S3 Fig. The relationship between the number of autophagic vacuoles and age in control
subjects (A), MCNS patients (B) and IMN patients (C). The number of autophagic vacuoles
were significantly correlated with age in the control subjects (n = 17) (A) and MCNS patients
(n = 41) (B), but not in the patients with IMN (n = 37) (C).
(TIF)
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